DUBLIN und MUMBAI, Indien, 2. Dezember 2025 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) („Cosmo") und Glenmark Pharmaceuticals Limited („Glenmark") gaben bekannt, dass die Europäische Kommission (EC) die Marktzulassung (MA) für Winlevi® (Clascoteron 10 mg/g Creme) erteilt hat,...
Hence then, the article about cosmo und glenmark geben die marktzulassung von winlevi clascoteron 10 mg g creme zur behandlung von akne in 17 landern in europa bekannt was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Cosmo und Glenmark geben die Marktzulassung von Winlevi® (Clascoteron) 10 mg/g Creme zur Behandlung von Akne in 17 Ländern in Europa bekannt )
Also on site :
- China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
- The shadow Russia casts over Europe has forced it to face the truth: the risk of war is once again real
- Prominent Canadian Musician Says Gig Was Cancelled After Google AI Overview Wrongly Branded Him Sex Pest